PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91025C00050PHASE i - development of therapeutic — Nomocan Pharmaceuticals LLC

Nomocan Pharmaceuticals LLC holds $499K across 2 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 16 offers. Set-aside status: SBA. Recompete timing centers on the Sep 14, 2026 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

Nomocan Pharmaceuticals LLC

Recipient

Sep 14, 2026

PoP end

$499K

Obligated

$499K

Potential

541715

NAICS

AN12

PSC

SBA

Set-aside

16 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Nomocan Pharmaceuticals LLC — $90

Contract facts

SBA

Contract number75N91025C00050

AgencyNih Nci

Awarding officeNih Nci

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentNomocan Pharmaceuticals LLC

CAGE7ER28

UEIH9T8M7ZBYAR8

NAICS541715

PSCAN12

Place of performanceNEW YORK NY

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

Related solicitation75N91024R00019

PoP startSep 15, 2025

PoP end (current)Sep 14, 2026

Obligated$499K

Current value$499K

Potential value$499K

PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTRIPTION. is a federal SBA award for Nih Nci held by Nomocan Pharmaceuticals LLC. Estimated value $499K ($499K obligated). Current period of performance ends Sep 14, 2026. Last award drew 16 bidders. Place of performance: NEW YORK NY. Related solicitation 75N91024R00019.

PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTRIPTION.

Recompete timing

Public

● Expiring in 7 days

Current PoP ends Sep 14, 2026 (7 days remaining). Agencies typically plan 12–18 months ahead — at 0.2 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Nomocan Pharmaceuticals LLC — $499K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$499K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91025C00050?

75N91025C00050 (PHASE i - development of therapeutic) is a Nih Nci award with a potential value of $499K, currently held by Nomocan Pharmaceuticals LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91025C00050?

Nih Nci awarded 75N91025C00050 to Nomocan Pharmaceuticals LLC (potential $499K).

Who is the incumbent on 75N91025C00050?

Nomocan Pharmaceuticals LLC is the incumbent with $499K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Sep 14, 2026.

When does Nomocan Pharmaceuticals LLC’s 75N91025C00050 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 14, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91025C00050 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action May 5, 2026